key: cord-0997016-ode2w76w
authors: Kim, Yong-Chan; Won, Sae-Young; Jeong, Byung-Hoon
title: The first association study of single-nucleotide polymorphisms (SNPs) of the IFITM1 gene with influenza H1N1 2009 pandemic virus infection
date: 2021-02-15
journal: Mol Cell Toxicol
DOI: 10.1007/s13273-021-00123-y
sha: f0e14f3b5f5393202b2fedc9f55d37158fde62df
doc_id: 997016
cord_uid: ode2w76w

BACKGROUND: The interferon-induced transmembrane (IFITM) protein family consists of interferon-stimulated genes (ISGs) that show potent antiviral capacity against a broad range of viruses. Many studies have been performed to investigate an association between IFITM3 polymorphisms and pandemic influenza A 2009 H1N1 virus infection. However, an association study of IFITM1 polymorphisms with susceptibility to this infection has not been reported thus far. OBJECTIVE: To identify an association between the susceptibility to pandemic influenza A 2009 H1N1 virus infection and IFITM1 polymorphisms, we compared genotype, allele and haplotype frequencies of the IFITM1 gene between healthy controls and pandemic influenza A 2009 H1N1-infected patients. In addition, we investigated linkage disequilibrium (LD) by Haploview 4.2 and the binding ability of transcription factors according to IFITM1 polymorphism alleles by PROMO. Furthermore, we measured the LD value between the IFITM1 gene and the IFITM3 gene. RESULTS: We found 3 novel single-nucleotide polymorphisms (SNPs) and did not find an association between IFITM1 SNPs and susceptibility to pandemic influenza A 2009 H1N1 virus infection. We found strong LD among IFITM1 SNPs but did not find a difference in the transcription factor-binding ability according to regulatory IFITM1 SNP alleles. In addition, we found strong LD between IFITM1 SNPs and IFITM3 SNPs. CONCLUSION: To the best of our knowledge, this report is the first association study of the susceptibility to pandemic influenza A 2009 H1N1 virus infection and IFITM1 polymorphisms.

In response to viral invasion, viral sensor proteins of the host immune system, including melanoma differentiationassociated gene-5 (MDA-5), retinoic acid-inducible gene 1 (RIG-1) and Toll-like receptors (TLRs), recognize viral antigens and activate interferon secretion (Uematsu and Akira 2007; Sarkar et al. 2008; Reikine et al. 2014; Brisse and Ly 2019) . Secreted interferon binds to interferon receptor (IFNR) and stimulates the expression of interferonstimulated genes (ISGs) mediated by the Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathway (Horvath 2004a, b; Schindler et al. 2007 ). Among various ISGs, previous studies have reported that the clustering of the interferon-induced transmembrane protein (IFITM) protein family showed potent antiviral capacity through blocking the internalization of a broad spectrum of viruses, including Ebola virus (EBOV), Marburg virus (MARV), severe acute respiratory syndrome coronavirus (SARS-CoV), dengue virus (DEV), West Nile virus (WNV), Zika virus (ZIKV) and influenza A virus (IAV) (Feeley et al. 2011; Bailey et al. 2012; Everitt et al. 2012; Diamond and Farzan 2013; Perreira et al. 2013; Bailey et al. 2014; Kim and Jeong 2017; Zani and Yount 2018; Bedford et al. 2019; Kim et al. 2019; Spence et al. 2019; Kim and Jeong 2021; Lee et al. 2019) .

In a recent study, genetic polymorphisms of the IFITM3 gene, a member of the IFITM protein family, were associated with the severity and/or susceptibility to pandemic influenza A 2009 H1N1 virus infection. The rs12252 single-nucleotide polymorphism (SNP), which is located in the splicing receptor site of the IFITM3 gene and induces the production of an N-terminal-truncated form of IFITM3 protein, is associated with the severity of pandemic influenza A 2009 H1N1 infection (Everitt et al. 2012; Zhang et al. 2013; Mills et al. 2014; Xuan et al. 2015; Gaio et al. 2016; Pan et al. 2017 ). In addition, the rs34481144 and rs6598045 SNPs, which are located in the transcriptional regulatory region of the IFITM3 gene, are also strongly related to the severity of and susceptibility to pandemic influenza A 2009 H1N1 virus infection, respectively (Allen et al. 2017; David et al. 2018; ). The IFITM1 protein, a member of the IFITM protein family, plays a pivotal role in the antiviral response of the host innate immune system. Unlike the IFITM3 protein, which is mainly expressed in the late endosome and prevents viral fusion, the IFITM1 protein mainly expressed in the cytosolic leaflet and blocks entry of viruses to the early endosome (Perreira et al. 2013) . However, there are no association studies of genetic polymorphisms of the IFITM1 gene with the susceptibility to pandemic influenza A 2009 H1N1 virus infection.

To identify an association between the susceptibility to pandemic influenza A 2009 H1N1 virus infection and IFITM1 polymorphisms, we investigated the genotype, allele and haplotype frequencies of the IFITM1 gene. In addition, we compared the genotype, allele and haplotype frequencies of the IFITM1 gene between healthy controls and pandemic influenza A 2009 H1N1-infected patients and estimated an association between the susceptibility to pandemic influenza A 2009 H1N1 virus infection and the IFITM1 polymorphisms. Furthermore, we investigated linkage disequilibrium (LD) by Haploview 4.2 and the binding ability of transcription factors according to IFITM1 polymorphism alleles by PROMO. Last, we measured the LD value between the IFITM1 and IFITM3 genes.

Detailed information on all participants was described in a previous study . All samples were provided with informed consent under institutional review board-approved protocols. All procedures performed in the present study were approved according to guidelines of the institutional review board (IRB) of Jeonbuk National University and in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards (approval number: JBNU 2017-08-009). All the samples and related data were anonymized prior to study.

Genomic DNA was extracted from 200 μl of whole blood using a Blood Genomic DNA Isolation Kit (Qiagen, Valencia, California, USA) following the manufacturer's recommendations.

The human IFITM1 gene was amplified from genomic DNA using sense and antisense gene-specific primers. The sequences of the primers were as follows: IFITM1-F (AGT GAG GTG AGG GCT TTT GG) and IFITM1-R (CAC AGT CAC AGG GAC ACA CA). Polymerase chain reaction (PCR) was carried out using GoTaq ® DNA Polymerase (Promega, Fitchburg, Wisconsin, USA). The PCR mixture contained 20 pmol of each primer, 5 μl of 10 × Taq DNA polymerase buffer, 1 μl of 10 mM dNTP mixture and 2.5 units of Taq DNA polymerase. The PCR conditions for the IFITM1-F and IFITM1-R primers were 94 °C for 2 min to denature; 35 cycles of 94 °C for 45 s, 71 °C for 45 s, and 72 °C for 1 min 30 s; and then 1 cycle of 72 °C for 10 min to extend the reaction. PCR was performed using an S-1000 Thermal Cycler (Bio-Rad, Hercules, California, USA). The PCR products were eluted by a PCR Purification Kit (Thermo Fisher Scientific, Bridgewater, New Jersey, USA) and directly sequenced with an ABI 3730 automatic sequencer (ABI, Foster City, California, USA). Sequencing results were read by Finch TV software (Geospiza Inc, Seattle, USA), and genotyping was performed.

Statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., USA). The differences in the distribution of genotypes, alleles and haplotypes of the IFITM1 gene between cases and control populations were analyzed using the χ 2 test. The Hardy-Weinberg equilibrium (HWE) test and haplotype analysis were performed using Haploview 4.2 (Broad Institute, Cambridge, MA, USA). LD analysis was performed using coefficient r 2 values by the program Haploview version 4.2 (Broad Institute, Cambridge, MA, USA).

Binding sites and transcription factors were predicted by PROMO (http://algge n.lsi.upc.es/cgi-bin/promo _v3/promo /promo init.cgi?dirDB =TF_8.3). The maximum matrix dissimilarity rate was entered as a "0" value. Four major haplotypes of proximal promoter sequences of the IFITM1 gene were identified and analyzed in this study.

To investigate the genotype and allele frequencies of IFITM1 gene polymorphisms in the Korean population, we performed direct sequencing in 175 healthy controls and 30 H1N1 pandemic influenza 2009 virus-affected patients. Detailed information on the participants is described in Table 1 . The sequenced products were homologous to the IFITM1 gene of Homo sapiens registered in GenBank (Gene ID: 8519). We found a total of 3 novel SNPs, c.-416C > G, c.-327A > C and c.186 + 18G > A (Fig. 1) . The c.-327A > C and c.186 + 18G > A SNPs were found in only healthy controls ( Table 2) .

To examine an association between the genetic distribution of the IFITM1 gene and susceptibility to H1N1 pandemic influenza 2009 virus infection, we compared the genotype, allele and haplotype frequencies of the IFITM1 gene polymorphisms between the healthy controls and H1N1 pandemic influenza 2009 virus-affected patients. Interestingly, genotype and allele frequencies of all 3 SNPs of the IFITM1 gene showed no association between healthy controls and H1N1 pandemic influenza 2009-affected patients (Table 2) . Detailed information on the genotype and allele frequencies of SNPs of the IFITM1 gene is described in Table 2 . To analyze the haplotype frequencies, we investigated the distribution of haplotypes using Haploview 4.2. Three major haplotypes were found in the SNPs of the human IFITM1 gene. The detailed degree of haplotype distribution is described in Table 3 . In brief, a statistical comparison of 3 major haplotypes showed no significant distribution (P > 0.9) between healthy controls and H1N1 pandemic influenza 2009 virus-affected patients. We also investigated the LD among the three IFITM1 SNPs with r 2 values. Notably, all the IFITM1 SNPs showed weak LD (r 2 < 0.3, Table 4 ).

We analyzed the binding capacity of transcription factors according to alleles of regulatory SNPs using PROMO. The proximal promoter located approximately 300 base pairs upstream of the transcription start site was classified into 4 major haplotypes, and the binding ability of transcription factors was predicted according to these haplotypes. Interestingly, there was no difference in the binding ability of transcription factors according to the 4 haplotypes of promoter sequences (Fig. 2) .

To examine whether the IFITM1 SNPs have genetic linkage with IFITM3 SNPs, LD analysis was carried out among SNPs of these two genes in heathy controls and H1N1 pandemic influenza 2009 virus-affected patients. Detailed values are described in Tables 5, 6. In healthy controls (Table 5) 

The IFITM1 protein is a member of the IFITM protein family, which is composed of IFITM 1, 2, 3, 5 and 10. IFITM family proteins are highly homologous with each other and contain a well-conserved CD225 domain, which consists of two major structures, transmembrane 1 and a conserved intracellular loop. The IFITM family in vertebrates can be divided into three subfamilies. IFITM1, 2 and 3 are crucial antiviral effectors, so these proteins can be classified into the immunity-related IFITM (IR-IFITM) subfamily. The IFITM1 gene is located 4.8 kb downstream of the IFITM3 gene, and the regulatory region of the IFITM3 gene affects translational regulation of the IFITM1 gene (Diamond and Farzan 2013; Smith et al. 2014; Zhao et al. 2018; Yanez et al. 2020) . Since there apparently is a structural and functional relationship between IFITM1 and IFITM3 genes and the IFITM3 gene showed a strong association with the severity of and susceptibility to pandemic influenza A 2009 H1N1 Since IFITM1 polymorphisms have not been investigated thus far, we first investigated the polymorphisms of the IFITM1 gene in the present study. We found a total of 3 novel SNPs, c.-416C > G, c.-327A > C and c.186 + 18G > A (Fig. 1, Table 2 ). In a previous study, we found 15 polymorphisms of the IFITM3 gene in Korean populations. However, in the present study, we found only 3 SNPs in the same test groups . Of these 3 IFITM1 SNPs, 2 SNPs are extremely rare SNPs, with a minor allele frequency of < 1% ( Table 2) . The difference in the number of SNPs between the IFITM1 and IFITM3 genes indicates that the IFITM1 gene is more relatively well conserved than the IFITM3 gene. However, this result could also be influenced by ethnic features or small sample sizes; thus, further investigation is needed to confirm polymorphic characteristics of the IFITM1 gene in larger and different ethnic groups.

We compared genotype, allele and haplotype frequencies of the IFITM1 gene between healthy controls and pandemic influenza A 2009 H1N1 virus-infected patients and evaluated an association between the susceptibility to pandemic influenza A 2009 H1N1 virus infection and the IFITM1 polymorphisms. Notably, there was no association between the susceptibility to pandemic influenza A 2009 H1N1 virus infection and IFITM1 polymorphisms (Table 2) . Previous studies have reported that the specificity of protection afforded by the IFITM3 protein against influenza A virus is higher than that for the IFITM1 protein, which may be the reason that no association between the susceptibility to pandemic influenza A 2009 H1N1 virus infection and IFITM1 polymorphisms was observed (Perreira et al. 2013 ). However, we annotated IFITM1 SNPs and found that 2 regulatory SNPs did not affect transcription factor-binding ability (Fig. 2 ). In addition, the remaining SNP did not disrupt splicing regulatory elements. Thus, since the IFITM1 SNPs has been shown to have no effect on the phenotype of the IFITM1 gene, nonfunctional IFITM1 SNPs found in this study can also be responsible for the lack of association between the susceptibility to pandemic influenza A 2009 H1N1 virus infection and IFITM1 polymorphisms. Further investigation of novel functional IFITM1 polymorphisms can be helpful to confirm this interpretation in the future. We found a strong genetic linkage between IFITM3 SNPs and IFITM1 c.-416C > G SNP. However, the degree of strong genetic linkage is different between healthy controls and influenza A H1N1-infected patients and the genetic LD of pandemic influenza A H1N1-infected patients showed weaker than that of healthy controls (Tables 5, 6 ). Thus, the weak genetic linkage between IFITM1 and IFITM3 SNPs is associated with various genotypes of these two genes and may be related to the various phenotypes of these two genes. Further analysis is needed to elucidate the association between the degree of LD value and the susceptibility of pandemic influenza A H1N1 virus infection. In addition, although the IFITM2 gene, another member of the IR-IFITM subfamily, is related to antiviral function, the IFITM2 protein showed a weaker antiviral effect than the IFITM3 protein in previous study (Perreira et al. 2013) . Further study of the relationship between the susceptibility of the influenza H1N1 virus infection and IFITM2 SNPs is highly desirable in the future.

In conclusion, we identified 3 novel SNPs of the IFITM1 gene. In addition, we investigated the genotype, allele and haplotype frequencies of the IFITM1 gene, analyzed the LD of this gene and evaluated an association between the susceptibility to pandemic influenza A 2009 H1N1 virus infection and the IFITM1 polymorphisms. Furthermore, we analyzed the binding ability of transcription factors according to the alleles of the IFITM1 SNPs and measured the LD values between the IFITM1 and IFITM3 genes. To the best of our knowledge, this report is the first association study between the susceptibility to pandemic influenza A 2009 H1N1 virus infection and IFITM1 polymorphisms.

SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans

Ifitm3 limits the severity of acute influenza in mice

IFITM-family proteins: the cell's first line of antiviral defense

Rapid interferon independent expression of IFITM3 following T cell activation protects cells from influenza virus infection

Comparative structure and function analysis of the RIG-I-like receptors: RIG-I and MDA5

Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity

The broad-spectrum antiviral functions of IFIT and IFITM proteins

IFITM3 restricts the morbidity and mortality associated with influenza

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry

Hospitalization risk due to respiratory illness associated with genetic variation at IFITM3 in patients with influenza A(H1N1)pdm09 infection: a case-control study

The Jak-STAT pathway stimulated by interferon alpha or interferon beta

The Jak-STAT pathway stimulated by interferon gamma

No correlation of the disease severity of influenza A virus infection with the rs12252 polymorphism of the interferon-induced transmembrane protein 3 gene

Ethnic variation in risk genotypes based on single nucleotide polymorphisms (SNPs) of the interferoninducible transmembrane 3 (IFITM3) gene, a susceptibility factor for pandemic 2009 H1N1 influenza A virus

Strong correlation between the case fatality rate of COVID-19 and the rs6598045 single nucleotide polymorphism (SNP) of the interferon-induced transmembrane protein 3 ( IFITM3) gene at the population-level

Genetic characteristics and polymorphisms in the chicken interferon-induced transmembrane protein (IFITM3) gene

Strong association of regulatory single nucleotide polymorphisms (SNPs) of the IFITM3 gene with influenza H1N1 2009 pandemic virus infection

Curcumin inhibits poly(dA:dT)-induced IL-18 secretion by inhibiting the ASC oligomerization in human keratinocytes

IFITM3 and susceptibility to respiratory viral infections in the community

Rs12252-C variant increases potential risk for severe influenza virus infection in Chinese population

IFITMs restrict the replication of multiple pathogenic viruses

Pattern recognition and signaling mechanisms of RIG-I and MDA5

Evolution of MDA-5/RIG-Idependent innate immunity: independent evolution by domain grafting

JAK-STAT signaling: from interferons to cytokines

IFITM proteinscellular inhibitors of viral entry

IFITM3 directly engages and shuttles incoming virus particles to lysosomes

Toll-like receptors and Type I interferons

IFITM3 rs12252 T>C polymorphism is associated with the risk of severe influenza: a meta-analysis

The IFITM protein family in adaptive immunity

Antiviral protection by IFITM3 in vivo

Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals

IFITM genes, variants, and their roles in the control and pathogenesis of viral infections

The biospecimens and data used in this study were provided by the Biobank of Chonbuk National University Hospital, a member of the Korea Biobank Network, which is supported by the Ministry of Health, Welfare and Family Affairs. All samples derived from the Korea Biobank Network were obtained with informed consent under institutional review board-approved protocols. Author contributions YCK, SYW and BHJ conceived and designed the experiments. YCK and SYW performed the experiments. YCK and BHJ analyzed the data. YCK, SYW and BHJ wrote the paper. All authors read and approved the final manuscript.

Ethical approval All procedures performed in the present study were accredited by the institutional review board of the Jeonbuk National University and were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards (Approval number: JBNU 2017-08-009).